ClinicalTrialStartPulse / compare

Lumicell, Inc. vs Lumicell, Inc.: ClinicalTrialStartPulse comparison

Lumicell, Inc.'s enrollment of 1,500 is 1.0x Lumicell, Inc.'s 1,500 (96th percentile). Lumicell, Inc. is dated 2026-10-22; Lumicell, Inc. 2026-10-22.

Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2

Both records plus every comparable US record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe

How does Lumicell, Inc. compare to Lumicell, Inc.?

FieldLumicell, Inc.Lumicell, Inc.
SponsorLumicell, Inc.Lumicell, Inc.
Sponsor typeIndustry (pharma, biotech, medtech)Industry (pharma, biotech, medtech)
StudyPost-market Safety Study of LUMISIGHTPost-market Evaluation of LumiSystem: Intraoperative Margin Performance and Clinical Utility (IMPACT) Registry
NCT IDNCT07572162NCT07616856
PhaseObservationalObservational
Statusrecruitingrecruiting
ConditionsHypersensitivity ReactionsBreast Cancer
Target enrollment15001500
Site countriesUnited StatesUnited States
Posted2026-05-072026-06-01
Planned start2026-09-302026-09-30
EventStarted recruitingStarted recruiting
Event date2026-09-302026-09-30
Last update posted2026-10-222026-10-22
enrollment percentile96th96th
Score90/10090/100
Peer rank and all 500 US records (CSV) 🔒 Click to unlock →
Official source URLs for every peer record 🔒 Click to unlock →

Official records: Lumicell, Inc. · Lumicell, Inc.

Get new studies in your therapeutic areas

ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.

See plans

From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.

Often used together